You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
8 July 2020 - - US-based contract research organization CTI Clinical Trial and Consulting Services will use US-based clinical trial solutions provider Medidata's Remote Source Review to power remote monitoring and document review for multiple gl...
8 July 2020 - - LYNPARZA has been approved in the European Union as a monotherapy for the maintenance treatment of adult patients with germline BRCA1/2 mutations who have metastatic adenocarcinoma of the pancreas and have not progressed after a ...
8 July 2020 - - Data presented at the 23rd International AIDS Conference (AIDS 2020: Virtual) evaluated the impact of COVID-19 shelter-in-place orders (SIPOs) and PrEP utilisation on HIV prevention strategies and associated risk behaviours, US-b...
8 July 2020 - - The US Food and Drug Administration has approved US-based biotechnology company Talaris Therapeutics, Inc's Investigational New Drug application for the evaluation of Talaris' novel cell therapy FCR001 in the treatment of di...
8 July 2020 - - Swiss RNAi therapeutics company Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) and UAE-based rare disease company taiba Middle East have formed a Distribution Agreement for both ONPATTRO and GIVLAARI, the first-ever commercial...
8 July 2020 - - UK-based threat detection and screening technologies provider Smiths Detection has partnered with Attomarker Ltd, a multiplex blood-testing technology company spun out of the University of Exeter, to help produce a robust and accurate...
8 July 2020 - - US-based Ridgeback Biotherapeutics has started enrollment in a Phase 2 trial of potential COVID-19 treatment EIDD-2801, the company said.
The new trial will be conducted using the new COVID-19 drug testing platform AGILE,...
The new trial will be conducted using the new COVID-19 drug testing platform AGILE,...